Geode Capital Management, LLC Affimed N.V. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.57 - $1.08 $739,373 - $1.4 Million	-1,297,147 Reduced 90.51%	135,947 $81,000
Q1 2023 May 15, 2023	BUY	$0.66 - $1.29 $44,426 - $86,833	67,313 Added 4.93%	1,433,094 $1.07 Million
Q4 2022 Feb 13, 2023	BUY	$1.1 - $2.45 $82,874 - $184,583	75,340 Added 5.84%	1,365,781 $1.69 Million
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.32 $207,548 - $351,561	105,892 Added 8.94%	1,290,441 $2.66 Million
Q2 2022 Aug 12, 2022	BUY	$2.27 - $4.86 $397,799 - $851,676	175,242 Added 17.36%	1,184,549 $3.28 Million
Q1 2022 May 13, 2022	SELL	$3.69 - $5.65 $222,661 - $340,932	-60,342 Reduced 5.64%	1,009,307 $4.41 Million
Q4 2021 Feb 11, 2022	SELL	$5.37 - $7.07 $7,109 - $9,360	-1,324 Reduced 0.12%	1,069,649 $5.9 Million
Q3 2021 Nov 12, 2021	BUY	$5.54 - $7.51 $1,756 - $2,380	317 Added 0.03%	1,070,973 $6.62 Million
Q2 2021 Aug 13, 2021	BUY	$7.78 - $11.4 $199,424 - $292,216	25,633 Added 2.45%	1,070,656 $9.1 Million
Q1 2021 May 12, 2021	BUY	$5.12 - $8.48 $1.34 Million - $2.23 Million	262,605 Added 33.56%	1,045,023 $8.27 Million
Q4 2020 Feb 12, 2021	BUY	$3.16 - $7.03 $325,201 - $723,471	102,912 Added 15.15%	782,418 $4.55 Million
Q3 2020 Nov 13, 2020	BUY	$3.26 - $4.73 $146,426 - $212,452	44,916 Added 7.08%	679,506 $2.3 Million
Q2 2020 Aug 13, 2020	BUY	$1.58 - $4.63 $4,248 - $12,450	2,689 Added 0.43%	634,590 $2.93 Million
Q1 2020 May 14, 2020	SELL	$1.44 - $3.02 $42,019 - $88,123	-29,180 Reduced 4.41%	631,901 $998,000
Q4 2019 Feb 13, 2020	BUY	$2.25 - $3.07 $234,650 - $320,167	104,289 Added 18.73%	661,081 $1.81 Million
Q3 2019 Nov 12, 2019	SELL	$2.67 - $3.65 $598,819 - $818,611	-224,277 Reduced 28.71%	556,792 $1.64 Million
Q2 2019 Aug 14, 2019	BUY	$2.6 - $4.21 $1.86 Million - $3.01 Million	714,995 Added 1082.11%	781,069 $2.24 Million
Q4 2018 Feb 13, 2019	BUY	$2.82 - $4.67 $41,888 - $69,368	14,854 Added 29.0%	66,074 $205,000
Q2 2018 Aug 14, 2018	BUY	$1.65 - $2.5 $68,013 - $103,050	41,220 Added 412.2%	51,220 $84,000
Q4 2017 Feb 13, 2018	SELL	$1.23 - $2.3 $10,779 - $20,157	-8,764 Reduced 46.71%	10,000 $13,000
Q2 2017 Aug 14, 2017	BUY	N/A	18,764	18,764 $38,000

Others Institutions Holding AFMD

# of Institutions

Shares Held

1.09M

Call Options Held

Put Options Held

View Full List

About Affimed N.V.

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

More about AFMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account